Akero Therapeutics (NASDAQ: AKRO) Transaction with Novo Nordisk Draws Legal Scrutiny
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameAkero Therapeutics Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









